Authors' objectives: The purpose of this HTA is to address the policy question through an assessment of the clinical effectiveness and safety, and cost-effectiveness, and patients’, partners’, and health care providers’ perspectives and experiences regarding the screening of pregnant persons for CT and GC. An analytic framework for the HTA can be found in Appendix 1.
Sexually transmitted diseases; Chlamydia trachomatis; Neisseria gonorrhoeae; Pregnancy
10.5
